Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dinçer Firat"'
Autor:
Charles D. Sherman, Kenneth C. Calman, Sandor Eckhardt, Ismail Elsebai, Dincer Firat, Dieter K. Hossfeld, Jean-Pierre Paunier, Bruno Salvadori
The continuing success of the VICC's Manual of Clinical Oncology and the continuing refinement of our educational objectives in cancer designed for graduating medical students and young practitioners, cou pled with significant additional knowledge
Autor:
Walter H. Traub, W. Maier, S. Špánik, N. M. Al-Gharably, Kohei Hara, M. Mistrík, Rinzo Soejima, L. Helpianska, Abdurrahman Kadayifçi, L. Drgoňa, I. Ilavská, D. Sorkovská, Charles B. Hanna, Denise S. Williams, E. Kukučková, J. Strutz, Hironobu Koga, John C.H. Steele, Ibrahim Gullu, Hiroyuki Kobayashi, T. Kollaár, A. Alev Gerceker, V. Krčméry, E. Oravcová, Mark A. Pierce, Atsushi Saito, Ayse Kars, Gülten Tekuzman, Masatoshi Konno, M. Raza, Görgün Akpek, Mustafa Benekli, Dorrya M. Sabah, Abdullah M. Al-Bekairi, Wen-Kuei Huang, Kevin W. Bailey, Birgit Leonhard, Cemil Savaş, Nilüfer Güler, Masaru Nasu, Robert W. Sidwell, Gülten Ötük, Abdel-Moneim M. Osman, Mohammed M. Al-Harbi, James L. Parker, Yung-Ching Liu, Othman A. Al-Shabanah, Deh-Lin Cheng, Emin Kansu, Shigeru Kohno, Kihachiro Shimizu, John H. Huffman, Dinçer Firat, Sheldon M. Markowitz, Min Hui Wong, A. Sakalová
Publikováno v:
Chemotherapy. 41:I-VI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b9d7d9ee43e5a9490a0337ea4eceea0
https://doi.org/10.1159/000239376
https://doi.org/10.1159/000239376
Autor:
Ismet Baran, Yavuz Ozisik, Nilüfer Güler, Esmen Baltali, M. Kadri Altundag, Dinçer Firat, Gülten Tekuzman
Publikováno v:
Tumori. 88(3)
Anthracyclines and taxanes are currently the most effective drugs in the treatment of metastatic breast carcinoma. The aim of this study was to determine the efficacy and toxicity of paclitaxel and doxorubicin combination in the first-line treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::536d093474b6b24492907c3ecdd7a05b
https://pubmed.ncbi.nlm.nih.gov/12195757
https://pubmed.ncbi.nlm.nih.gov/12195757
Autor:
Ibrahim Güllü, Şuayib Yalçin, GÜLten Tekuzman, Ibrahim Barişlta, Necati Alkiş, Ismail Çelik, Nurullah Zengin, NilÜFer Güler, AyŞE Kars, EŞMen Baltali, Emin Kansu, DinÇEr Firat
Publikováno v:
Scopus-Elsevier
Twenty patients with advanced sarcomas entered a pilot study with ifosfamide (IF) and mercaptoethane sulfonate sodium (Mesna) as a second-line treatment for six planned cycles. All patients had received prior doxorubicin- and cyclophosphamide-based c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77d4b7d00df0e50470748b9d20e22457
http://www.scopus.com/inward/record.url?eid=2-s2.0-9444298411&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-9444298411&partnerID=MN8TOARS